These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10835843)

  • 21. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.
    Marr KA; Seidel K; Slavin MA; Bowden RA; Schoch HG; Flowers ME; Corey L; Boeckh M
    Blood; 2000 Sep; 96(6):2055-61. PubMed ID: 10979947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total intestinal decontamination for prevention of infection in bone marrow transplantation.
    Funada H; Teshima H; Hattori K
    Jpn J Clin Oncol; 1983; 13 Suppl 1():111-26. PubMed ID: 6339774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation.
    Ehninger G; Schuler HK; Sarnow E
    Mycoses; 1996; 39(7-8):259-63. PubMed ID: 9009642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
    Martino R; Nomdedéu J; Altés A; Sureda A; Brunet S; Martínez C; Domingo-Albós A
    Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Alonso R; del Valle O; Hernández-Molina JM; McNicholas P; Loebenberg D; Santos P
    J Antimicrob Chemother; 2005 Mar; 55(3):317-9. PubMed ID: 15705637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of fluconazole and selective digestive decontamination in the prevention of fungal infection after adult liver transplantation.
    Decruyenaere J; Colardyn F; Vogelaers D; Claeys G; Hesse U; De Deyne C; Hoste E; Lutz-Dettinger N; Vandewoude K; de Hemptinne B
    Transplant Proc; 1995 Dec; 27(6):3515-6. PubMed ID: 8540077
    [No Abstract]   [Full Text] [Related]  

  • 29. Elution and mechanical properties of antifungal bone cement.
    Goss B; Lutton C; Weinrauch P; Jabur M; Gillett G; Crawford R
    J Arthroplasty; 2007 Sep; 22(6):902-8. PubMed ID: 17826283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
    Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infections.
    Stewart A; Powles R; Hewetson M; Antrum J; Richardson C; Mehta J
    Pharmacoeconomics; 1995 Oct; 8(4):350-61. PubMed ID: 10155676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
    Wingard JR; Merz WG; Rinaldi MG; Johnson TR; Karp JE; Saral R
    N Engl J Med; 1991 Oct; 325(18):1274-7. PubMed ID: 1669837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
    J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
    Mallié M; Bastide JM
    Drugs Exp Clin Res; 1996; 22(6):301-7. PubMed ID: 9034756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
    Malik IA; Moid I; Aziz Z; Khan S; Suleman M
    Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous amphotericin B as prevention of deep mycoses in allogeneic bone marrow transplantation].
    Carreras E; Batlle M; Redondo M; Esteve J; Ros S; Rovira M; Sierra J; Urbano-Ispizua A; Marín P; Merino A
    Med Clin (Barc); 1994 Dec; 103(20):761-5. PubMed ID: 7861833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
    Mahdy RA; Nada WM; Wageh MM
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.